On this episode of Stock Movers:
- Sanofi’s experimental drug for the skin condition atopic dermatitis disappointed investors in a late stage trial, after the benefit of the drug was less than expected.
- Jet2 fell 25%. Trading volume was six times the average for this time of day. The stock reversed the previous session's gain.
- A year after losing its spot in Britain’s blue-chip benchmark, Burberry is returning to the UK’s stock-market elite. The luxury-goods maker, best known for its tartan-plaid trench coats, will rejoin the FTSE 100 Index later this month, index compiler FTSE Russell said Wednesday.

Meta Gains on Cloud Report, Bending Spoons Shares Soar in Debut, Nike Higher
04:51

Stock Movers: Meta Rises on Cloud Infrastructure, Coreweave Sinks, Bending Spoons IPOs
08:55

AOL Owner Bending Spoons Jumps After IPO, Nike Rises, Meta Plans New Cloud Business
04:00